Visit-to-visit fasting plasma glucose variability is an important risk factor for long-term changes in left cardiac structure and function in patients with type 2 diabetes

Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus

(2018) Jun Gu et al.   Cardiovascular Diabetology

Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes

(2018) Daisuke Matsutani et al.   Cardiovascular Diabetology

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

(2018) C. R. L. Cardoso et al.   Cardiovascular Diabetology

Trajectories of fasting plasma glucose variability and mortality in type 2 diabetes

(2018) Chia-Lin Lee et al.   DIABETES & METABOLISM

Duration of Diabetes and Prediabetes During Adulthood and Subclinical Atherosclerosis and Cardiac Dysfunction in Middle Age: The CARDIA Study

(2018) Jared P. Reis et al.   DIABETES CARE

Glycemic variability determined with a continuous glucose monitoring system can predict prognosis after acute coronary syndrome

(2018) Hironori Takahashi et al.   Cardiovascular Diabetology

Relationship of Hyperglycaemia, Hypoglycaemia, and Glucose Variability to Atherosclerotic Disease in Type 2 Diabetes

(2018) Caroline Jane Magri et al.   Journal of Diabetes Research

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2018) Melanie J. Davies et al.   DIABETES CARE

2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

(2018) Bryan Williams et al.   JOURNAL OF HYPERTENSION

Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias

(2017) Alberico L. Catapano et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Association of Insulin Resistance and Glycemic Metabolic Abnormalities With LV Structure and Function in Middle Age

(2017) Satoru Kishi et al.   JACC-Cardiovascular Imaging

Glycemic variability evaluated by continuous glucose monitoring system is associated with the 10-y cardiovascular risk of diabetic patients with well-controlled HbA1c

(2016) Xixiang Tang et al.   CLINICA CHIMICA ACTA

Evidence of left atrial remodeling and left ventricular diastolic dysfunction in type 2 diabetes mellitus with preserved systolic function

(2016) G. Zoppini et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Early Detection of Left Atrial Energy Loss and Mechanics Abnormalities in Diabetic Patients with Normal Left Atrial Size: A Study Combining Vector Flow Mapping and Tissue Tracking Echocardiography

(2016) Yi Wang et al.   MEDICAL SCIENCE MONITOR

Fasting plasma glucose variability and all-cause mortality among type 2 diabetes patients: a dynamic cohort study in Shanghai, China

(2016) Dongli Xu et al.   Scientific Reports

Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus

(2015) Yasuhide Mochizuki et al.   Cardiovascular Diabetology

Targeting metabolic disturbance in the diabetic heart

(2015) Jesús Fuentes-Antrás et al.   Cardiovascular Diabetology

Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes

(2015) Ricardo Fontes-Carvalho et al.   Cardiovascular Diabetology

Subendocardial Systolic Dysfunction in Asymptomatic Normotensive Diabetic Patients

(2015) Mami Enomoto et al.   CIRCULATION JOURNAL

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes

(2015) Petar M. Seferović et al.   EUROPEAN HEART JOURNAL

Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study

(2014) Cheng-Chieh Lin et al.   BMC Medicine

Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

(2014) Yoichiro Hirakawa et al.   DIABETES CARE

Molecular mechanisms of diabetic cardiomyopathy

(2014) Heiko Bugger et al.   DIABETOLOGIA

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Differential Changes of Left Ventricular Myocardial Deformation in Diabetic Patients with Controlled and Uncontrolled Blood Glucose: A Three-Dimensional Speckle-Tracking Echocardiography–Based Study

(2013) Xiaoling Zhang et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Influence of the glucose-lowering rate on left ventricular function in patients with type 2 diabetes and coronary heart disease

(2012) Weihua Wu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Combination of the Framingham Risk Score and Carotid Intima-Media Thickness Improves the Prediction of Cardiovascular Events in Patients With Type 2 Diabetes

(2011) M. Yoshida et al.   DIABETES CARE

Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: Is It Really the First Marker of Diabetic Cardiomyopathy?

(2011) Laura Ernande et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Longitudinal Left Ventricular Function in Normotensive Prediabetics: A Tissue Doppler and Strain/Strain Rate Echocardiography Study

(2011) Köksal Ceyhan et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Changes in Diastolic Dysfunction in Diabetes Mellitus Over Time

(2009) Aaron M. From et al.   AMERICAN JOURNAL OF CARDIOLOGY

Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

(2009) Mikael Kjaer Poulsen et al.   Circulation-Cardiovascular Imaging

Optimized Postprandial Glucose Control is Associated with Improved Cardiac/Vascular Function – Comparison of Three Insulin Regimens in Well-controlled Type 2 Diabetes

(2009) H. von Bibra et al.   HORMONE AND METABOLIC RESEARCH

A1C Variability and the Risk of Microvascular Complications in Type 1 Diabetes: Data from the Diabetes Control and Complications Trial

(2008) E. S. Kilpatrick et al.   DIABETES CARE

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

(2008) M. R. MacDonald et al.   EUROPEAN HEART JOURNAL

Cardiac Oxidative Stress Is Elevated at the Onset of Dilated Cardiomyopathy in Streptozotocin-Diabetic Rats

(2008) María J. Crespo et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS